McKnight's October 5, 2023
As COVID-19 continues to circulate, the US Food and Drug Administration (FDA) granted an updated emergency use authorization for the Novavax COVID-19 vaccine on Tuesday. The new vaccine will be available in the coming days, the company says.
The news about the Novavax vaccine comes as Moderna, one of the three companies that makes COVID-19 vaccines, announced it is testing a combination vaccine against the flu and COVID-19. Older people such as those in long-term care communities are advised to take COVID-19 shots, according to the US Centers for Disease Control and Prevention (CDC).
The newly approved Novavax vaccine specifically targets omicron subvariant XBB.1.5, and was approved for emergency use in people ages 12 and older. The protein-based...
Today's Sponsors
Today's Sponsor